These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21094355)

  • 21. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography.
    Vergallo R; Yonetsu T; Uemura S; Park SJ; Lee S; Kato K; Jia H; Abtahian F; Tian J; Hu S; Lee H; McNulty I; Prasad A; Yu B; Zhang S; Porto I; Biasucci LM; Crea F; Jang IK
    Am J Cardiol; 2013 Nov; 112(9):1315-21. PubMed ID: 23891431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents.
    Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Am J Cardiol; 2005 Jan; 95(1):107-9. PubMed ID: 15619404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis.
    Sano K; Mintz GS; Carlier SG; Fujii K; Takebayashi H; Kimura M; Costa JR; Tanaka K; Costa RA; Lui J; Weisz G; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps EM; Collins M; Stone GW; Moses JW; Leon MB
    Am J Cardiol; 2006 Dec; 98(12):1559-62. PubMed ID: 17145209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent.
    Oyabu J; Ueda Y; Ogasawara N; Okada K; Hirayama A; Kodama K
    Am Heart J; 2006 Dec; 152(6):1168-74. PubMed ID: 17161071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials.
    Aoki J; Mintz GS; Weissman NJ; Mann JT; Cannon L; Greenberg J; Grube E; Masud AR; Koglin J; Mandinov L; Stone GW
    JACC Cardiovasc Interv; 2008 Apr; 1(2):161-7. PubMed ID: 19463294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial gray scale intravascular ultrasound findings in late drug-eluting stent restenosis.
    Hakim DA; Mintz GS; Sanidas E; Rusinova R; Weisz G; Leon MB; Moses JW; Stone GW; Maehara A
    Am J Cardiol; 2013 Mar; 111(5):695-9. PubMed ID: 23273714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution pattern of neointimal hyperplasia following sirolimus-eluting stent implantation assessed by 3-dimensional intravascular ultrasound.
    Kaneda H; Ako J; Terashima M; Waseda K; Yock PG; Fitzgerald PJ
    Int J Cardiol; 2009 Jun; 135(2):243-5. PubMed ID: 18571251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vivo iMap IVUS comparison of in-stent neointima and native coronary atherosclerosis.
    Trusinskis K; Strenge K; Juhnevica D; Erglis A
    Cardiovasc Revasc Med; 2015 Jun; 16(4):233-6. PubMed ID: 25980925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents.
    Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Am J Cardiol; 2005 Jan; 95(1):105-7. PubMed ID: 15619403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New methods of coronary imaging II. Intracoronary ultrasonography in clinical practice].
    Sgura FA; Di Mario C
    Ital Heart J Suppl; 2001 Jun; 2(6):579-92. PubMed ID: 11460831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation.
    Suzuki Y; Ikeno F; Koizumi T; Tio F; Yeung AC; Yock PG; Fitzgerald PJ; Fearon WF
    JACC Cardiovasc Interv; 2008 Apr; 1(2):168-73. PubMed ID: 19463295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of in-stent minimal lumen area at 9 months poststent implantation on 3-year target lesion revascularization-free survival: a serial intravascular ultrasound analysis from the TAXUS IV, V, and VI trials.
    Doi H; Maehara A; Mintz GS; Weissman NJ; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Stone GW
    Circ Cardiovasc Interv; 2008 Oct; 1(2):111-8. PubMed ID: 20031665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anatomical and Physiological Changes after Paclitaxel-Coated Balloon for Atherosclerotic De Novo Coronary Lesions: Serial IVUS-VH and FFR Study.
    Ann SH; Balbir Singh G; Lim KH; Koo BK; Shin ES
    PLoS One; 2016; 11(1):e0147057. PubMed ID: 26824602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of neointimal morphology of in-stent restenosis with sirolimus-eluting stents versus bare metal stents: virtual histology-intravascular ultrasound analysis.
    Yamamoto Y; Otani H; Iwasaka J; Park H; Sakuma T; Kamihata H; Iwasaka T
    Cardiovasc Interv Ther; 2011 Sep; 26(3):186-92. PubMed ID: 24122584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and design: impact of intravascular ultrasound guidance on long-term clinical outcomes of everolimus-eluting stents in long coronary lesions.
    Cho S; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Contemp Clin Trials; 2015 Jan; 40():90-4. PubMed ID: 25433202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of stent design and stent surface material to subsequent in-stent intimal hyperplasia in coronary arteries determined by intravascular ultrasound.
    Hoffmann R; Mintz GS; Haager PK; Bozoglu T; Grube E; Gross M; Beythien C; Mudra H; vom Dahl J; Hanrath P
    Am J Cardiol; 2002 Jun; 89(12):1360-4. PubMed ID: 12062728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation.
    Gao RL; Xu B; Chen JL; Yang YJ; Qiao SB; Li JJ; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J
    Am Heart J; 2008 Mar; 155(3):553-61. PubMed ID: 18294496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.